Rockwell Medical is an innovative leader in producing and delivering a portfolio of hemodialysis products, including concentrates (solutions and powders) and related ancillaries, to dialysis providers in the United States and internationally. Rockwell is the second largest supplier of acid and bicarbonate concentrates for dialysis patients in the United States. The Company is dedicated to providing the hemodialysis community with the highest quality products supported by the most reliable delivery service in the industry.
Ferric Pyrophosphate Citrate (FPC)
Our innovative therapeutic was developed to replace iron loss in patients with anemia in an entirely different way. Our unique and differentiated molecule, Ferric Pyrophosphate Citrate (FPC), provides a novel mechanism of action with a physiologic approach. FPC donates iron directly to circulating transferrin making it immediately bioavailable for critical body processes, which allows the body to use the iron in a physiologic manner.
December 13, 2022
Rockwell Medical Begins Selling its Hemodialysis Concentrates Products to New Clinics in Minnesota with its Largest CustomerRead more
November 14, 2022
Rockwell Medical Provides Business Strategy Update and Announces Third Quarter 2022 Financial and Operational ResultsRead more
November 9, 2022
Rockwell Medical Reacquires Distribution Rights for its Hemodialysis Concentrates Business from BaxterRead more
October 17, 2022
Rockwell Medical to Release Third Quarter 2022 Financial Results on Monday, November 14Read more
September 14, 2022
Rockwell Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)Read more